Cargando…

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development

BACKGROUND: Mechanistic within-host models relating blood anti-malarial drug concentrations with the parasite-time profile help in assessing dosing schedules and partner drugs for new anti-malarial treatments. A comprehensive simulation study to assess the utility of a stage-specific pharmacokinetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaloumis, Sophie, Humberstone, Andrew, Charman, Susan A, Price, Ric N, Moehrle, Joerg, Gamo-Benito, Javier, McCaw, James, Jamsen, Kris M, Smith, Katherine, Simpson, Julie A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546862/ https://www.ncbi.nlm.nih.gov/pubmed/22931058 http://dx.doi.org/10.1186/1475-2875-11-303

Ejemplares similares

Towards optimal design of anti-malarial pharmacokinetic studies
por: Simpson, Julie A, et al.
Publicado: (2009)

A robust design for identification of the Parasite Clearance Estimator
por: Jamsen, Kris M, et al.
Publicado: (2013)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
por: Jamsen, Kris M, et al.
Publicado: (2011)

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
por: Jamsen, Kris M, et al.
Publicado: (2012)

Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling
por: Dini, Saber, et al.
Publicado: (2018)

Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection
por: Yan, Ada W. C., et al.
Publicado: (2019)

Nonlinear Mixed-Effects Modelling of In Vitro Drug Susceptibility and Molecular Correlates of Multidrug Resistant Plasmodium falciparum
por: Simpson, Julie A., et al.
Publicado: (2013)

Grading fluorescein angiograms in malarial retinopathy
por: MacCormick, Ian J. C., et al.
Publicado: (2015)

Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay
por: Linares, María, et al.
Publicado: (2015)

Population Pharmacokinetics of Intravenous Artesunate: A Pooled Analysis of Individual Data From Patients With Severe Malaria
por: Zaloumis, S G, et al.
Publicado: (2014)

Modeling the dynamics of Plasmodium falciparum gametocytes in humans during malaria infection
por: Cao, Pengxing, et al.
Publicado: (2019)

Automated and unsupervised detection of malarial parasites in microscopic images
por: Purwar, Yashasvi, et al.
Publicado: (2011)

A framework for assessing the risk of resistance for anti-malarials in development
por: Ding, Xavier C, et al.
Publicado: (2012)

New molecular settings to support in vivo anti-malarial assays
por: Bahamontes-Rosa, Noemí, et al.
Publicado: (2016)

A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine
por: Leong, F. Joel, et al.
Publicado: (2018)

The development and validation of an LC-MS/MS method for the determination of a new anti-malarial compound (TK900D) in human whole blood and its application to pharmacokinetic studies in mice
por: Abay, Efrem T, et al.
Publicado: (2014)

Improved negative selection protocol for Plasmodium berghei in the rodent malarial model
por: Orr, Rachael Y, et al.
Publicado: (2012)

The ACTwatch project: methods to describe anti-malarial markets in seven countries
por: Shewchuk, Tanya, et al.
Publicado: (2011)

Quantum dots: a new tool for anti-malarial drug assays
por: Ku, Min-Je, et al.
Publicado: (2011)

Dried blood spots as a source of anti-malarial antibodies for epidemiological studies
por: Corran, Patrick H, et al.
Publicado: (2008)

Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay
por: Rebelo, Maria, et al.
Publicado: (2015)

Methods for implementing a medicine outlet survey: lessons from the anti-malarial market
por: O’Connell, Kathryn A, et al.
Publicado: (2013)

Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs
por: Tougan, Takahiro, et al.
Publicado: (2019)

Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations
por: Khalil, Insaf F, et al.
Publicado: (2011)

A simple and inexpensive haemozoin-based colorimetric method to evaluate anti-malarial drug activity
por: Men, Tran Thanh, et al.
Publicado: (2012)

Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling
por: Hodel, Eva Maria, et al.
Publicado: (2014)

Development of a genetic tool for functional screening of anti-malarial bioactive extracts in metagenomic libraries
por: Mongui, Alvaro, et al.
Publicado: (2015)

Pill characterization data streams for reducing exposure to inadequately identified anti-malarial medication in developing countries
por: Pennefather, Peter, et al.
Publicado: (2010)

Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study
por: Ozawa, Sachiko, et al.
Publicado: (2019)

4512 Allopregnanolone Dose Finding for Status Epilepticus Treatment by Pharmacokinetic-Pharmacodynamic Modeling using Quantitative EEG in Dogs
por: Patterson, Edward “Ned”, et al.
Publicado: (2020)

One-step concentration of malarial parasite-infected red blood cells and removal of contaminating white blood cells
por: Trang, Dai Thi Xuan, et al.
Publicado: (2004)

Multiple treatment comparisons in a series of anti-malarial trials with an ordinal primary outcome and repeated treatment evaluations
por: Youdom, Solange Whegang, et al.
Publicado: (2012)

A lactate dehydrogenase ELISA-based assay for the in vitro determination of Plasmodium berghei sensitivity to anti-malarial drugs
por: Orjuela-Sánchez, Pamela, et al.
Publicado: (2012)

COIL: a methodology for evaluating malarial complexity of infection using likelihood from single nucleotide polymorphism data
por: Galinsky, Kevin, et al.
Publicado: (2015)

Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials
por: Combrinck, Jill M., et al.
Publicado: (2015)

Characterization and optimization of the haemozoin-like crystal (HLC) assay to determine Hz inhibiting effects of anti-malarial compounds
por: Tempera, Carolina, et al.
Publicado: (2015)

Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by Next Generation Sequencing of Plasmodium falciparum
por: Smith-Aguasca, Rebecca, et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Posaconazole
por: Chen, Lu, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
por: McCarthy, Matthew William
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s2e5rs0cidcnv5mgk608q6ra2v